Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Inorg Chem ; 62(10): 4043-4047, 2023 Mar 13.
Article in English | MEDLINE | ID: mdl-36847330

ABSTRACT

The assembly of supertetrahedral chalcogenolate clusters (SCCs) and multifunctional organic linkers could lead to the formation of tunable structures and synergistic properties. Two SCC-based assembled materials (SCCAM-1 and -2) constructed by a triangular chromophore ligand, tris(4-pyridylphenyl)amine, were successfully synthesized and characterized. The SCCAMs demonstrate unusually long-lived afterglow at low temperatures (83 K) and efficient activities for the photocatalytic degradation of organic dye in water.

2.
Nat Commun ; 13(1): 6296, 2022 10 22.
Article in English | MEDLINE | ID: mdl-36272974

ABSTRACT

Esophageal squamous cell carcinoma (ESCC) demonstrates high genome instability. Here, we analyze 528 whole genomes to investigate structural variations' mechanisms and biological functions. SVs show multi-mode distributions in size, indicating distinct mutational processes. We develop a tool and define five types of complex rearrangements with templated insertions. We highlight a type of fold-back inversion, which is associated with poor outcomes. Distinct rearrangement signatures demonstrate variable genomic metrics such as replicating time, spatial proximity, and chromatin accessibility. Specifically, fold-back inversion tends to occur near the centrosome; TD-c2 (Tandem duplication-cluster2) is significantly enriched in chromatin-accessibility and early-replication region compared to other signatures. Analyses of TD-c2 signature reveal 9 TD hotspots, of which we identify a hotspot consisting of a super-enhancer of PTHLH. We confirm the oncogenic effect of the PTHLH gene and its interaction with enhancers through functional experiments. Finally, extrachromosomal circular DNAs (ecDNAs) are present in 14% of ESCCs and have strong selective advantages to driver genes.


Subject(s)
Carcinoma, Squamous Cell , Esophageal Neoplasms , Esophageal Squamous Cell Carcinoma , Humans , Esophageal Squamous Cell Carcinoma/genetics , Esophageal Neoplasms/genetics , Esophageal Neoplasms/pathology , Carcinoma, Squamous Cell/genetics , Carcinoma, Squamous Cell/pathology , Chromatin/genetics , China , DNA, Circular
3.
Sci Rep ; 11(1): 19498, 2021 09 30.
Article in English | MEDLINE | ID: mdl-34593894

ABSTRACT

Optical coherence tomography (OCT) images is widely used in ophthalmic examination, but their qualities are often affected by noises. Shearlet transform has shown its effectiveness in removing image noises because of its edge-preserving property and directional sensitivity. In the paper, we propose an adaptive denoising algorithm for OCT images. The OCT noise is closer to the Poisson distribution than the Gaussian distribution, and shearlet transform assumes additive white Gaussian noise. We hence propose a square-root transform to redistribute the OCT noise. Different manufacturers and differences between imaging objects may influence the observed noise characteristics, which make predefined thresholding scheme ineffective. We propose an adaptive 3D shearlet image filter with noise-redistribution (adaptive-SIN) scheme for OCT images. The proposed adaptive-SIN is evaluated on three benchmark datasets using quantitative evaluation metrics and subjective visual inspection. Compared with other algorithms, the proposed algorithm better removes noise in OCT images and better preserves image details, significantly outperforming in terms of both quantitative evaluation and visual inspection. The proposed algorithm effectively transforms the Poisson noise to Gaussian noise so that the subsequent shearlet transform could optimally remove the noise. The proposed adaptive thresholding scheme optimally adapts to various noise conditions and hence better remove the noise. The comparison experimental results on three benchmark datasets against 8 compared algorithms demonstrate the effectiveness of the proposed approach in removing OCT noise.


Subject(s)
Models, Theoretical , Retina/diagnostic imaging , Signal-To-Noise Ratio , Tomography, Optical Coherence/methods , Tomography, Optical Coherence/standards , Algorithms , Image Processing, Computer-Assisted , Imaging, Three-Dimensional , Tomography, Optical Coherence/instrumentation
4.
J Exp Clin Cancer Res ; 29: 71, 2010 Jun 16.
Article in English | MEDLINE | ID: mdl-20565704

ABSTRACT

BACKGROUND: SPARC (secreted protein, acidic and rich in cysteine) is closely related with the progress, invasion and metastasis of malignant tumor and angiogenesis. METHODS: Using human colon adenocarcinoma tissues (hereinafter referred to as colon cancer) and their corresponding non-diseased colon from 114 patients' biopsies, the expression of SPARC and vascular endothelial growth factor (VEGF) were investigated by immunohistochemistry staining to assessment the relationship between SPARC and VEGF, as well as their prognostic significance in patients. Evaluation of VEGF expression level with the same tissues was used to establish the antigenic profiles, and the marker of CD34 staining was used as an indicator of microvessel density (MVD). RESULTS: SPARC expression was mainly in the stromal cells surrounding the colon cancer, and was significant difference in those tissues with the lymph node metastasis and differentiation degree of tumor. Expression of SPARC was significantly correlated with the expression of VEGF and MVD in colon cancer tissues. Patients with low or absence expressing SPARC had significantly worse overall survival and disease-free survival in a Single Factor Analysis; Cox Regression Analysis, SPARC emerged as an overall survival and disease-free survival independent prognostic factor for colon cancer. CONCLUSION: The low expression or absence of stromal SPARC was an independent prognostic factor for poor prognosis of colon cancer. SPARC maybe involved in the regulation of anti-angiogenesis by which it may serve as a novel target for colon cancer treatment as well as a novel distinctive marker.


Subject(s)
Adenocarcinoma/metabolism , Biomarkers, Tumor/metabolism , Colonic Neoplasms/metabolism , Osteonectin/metabolism , Vascular Endothelial Growth Factor A/metabolism , Adenocarcinoma/pathology , Colonic Neoplasms/pathology , Female , Humans , Immunoenzyme Techniques , Lymphatic Metastasis , Male , Microvessels/metabolism , Microvessels/pathology , Middle Aged , Prognosis , Stromal Cells/metabolism , Stromal Cells/pathology
5.
Int J Gynecol Pathol ; 29(1): 55-62, 2010 Jan.
Article in English | MEDLINE | ID: mdl-19952936

ABSTRACT

It can sometimes be difficult to distinguish between the 2 main types of uterine mesenchymal neoplasms; uterine smooth muscle tumors (SMTs) and endometrial stromal sarcomas (ESSs), particularly when the ESSs show smooth muscle differentiation or the SMTs are highly cellular. The aim of this study was to investigate myocardin expression in normal uterus myometrium, in SMTs, and in ESSs and to determine whether myocardin can be used as a useful diagnostic tool in the classification of problematic uterine mesenchymal tumors. Immunohistochemical staining was performed in each group. Besides myocardin, all cases were also stained for other smooth muscle markers (h-caldesmon, desmin, smooth muscle actin) and for CD10. All tested markers were analyzed in 21 conventional leiomyomas (LMs), 21 highly cellular leiomyomas (HCLs), 12 leiomyosarcomas (LMSs), 3 endometrial stromal nodules (ESNs), 11 ESSs, and 15 normal uterus myometrium. Myocardin was expressed in all normal uterine myometrium and in SMTs (even in the regions with epithelioid features) moderately or strongly, at least topically, whereas in endometrium, in ESNs and in ESSs, except in the regions of smooth muscle differentiation, it was negative. All ESNs, 11 of 11 ESSs and 14 of 15 endometrium were negative for h-caldesmon, but all SMTs and normal uterine myometrium were positive for h-caldesmon except for 2 LMSs, 2 HCLs, and for the regions with epithelioid features in 2 LMs. Desmin was stained in all normal uterine myometrium and in SMTs (except those of the regions with epithelioid features), but it was negative in 1 HCL and 1 LMS. One of 3 ESNs and 2 of 11 ESSs were expressed in desmin. Smooth muscle actin was negative in all ESNs, 2 LMSs, and 2 HCLs, and positive in all myometriums, LMs (except for the regions with epithelioid features), 1 ESSs, and 1 proliferative phase endometrium. Eight of 11 ESSs and all ESNs were positive for CD10, as was 1 HCL, and 2 LMSs. All uterine myometrium, 3 ESSs, and 3 endometriums were negative for CD10. Our study indicates that the myocardin is expressed in normal and neoplastic uterine smooth muscle cells sensitively and that the evaluation of myocardin expression is useful in distinguishing SMTs from ESSs.


Subject(s)
Endometrial Neoplasms/classification , Nuclear Proteins/biosynthesis , Sarcoma, Endometrial Stromal/classification , Smooth Muscle Tumor/classification , Trans-Activators/biosynthesis , Uterine Neoplasms/classification , Biomarkers, Tumor/analysis , Diagnosis, Differential , Endometrial Neoplasms/metabolism , Endometrial Neoplasms/pathology , Female , Humans , Immunohistochemistry , Sarcoma, Endometrial Stromal/metabolism , Sarcoma, Endometrial Stromal/pathology , Smooth Muscle Tumor/metabolism , Smooth Muscle Tumor/pathology , Uterine Neoplasms/metabolism , Uterine Neoplasms/pathology , Uterus/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...